Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d20e60a378e247520019241b16b56e6f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate |
2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_088d0624499e75e854fd2ac2289acab7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d35ff9bda3d6617a5080f5827f2aff57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b7f5c5c9463951c2b56543cc74b373e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f72ffbd1078f3ac886f4f730879345dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b36b22cfff8dd6c3728dceca118f161c |
publicationDate |
2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1860109-A1 |
titleOfInvention |
Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders |
abstract |
The present invention relates to novel azetidine amino pyrimidine compounds of formula (I) for the modulation of the histamine H4 receptor and the treatment or prevention of conditions mediated by the histamine H4 receptor. The invention also relates to the preparation of such compounds. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10700291-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10193086-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11600789-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9905782-B2 |
priorityDate |
2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |